Multicenter protocol in treating patients with childhood acute myeloid leukemia. Randomized study of maintenance treatment with interleukin-2.
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Aldesleukin (Primary)
- Indications Acute myeloid leukaemia
- Focus Registrational; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 05 Dec 2005 New trial record.